Amedisys beats profit forecast

Baton Rouge-based Amedisys Inc., one of the nation’s largest home health and hospice companies, posted a second-quarter profit of $7.6 million, or 23 cents per share, handily beating the company’s forecast from late June by cutting costs.

Amedisys’ results also were well above those from the second quarter of 2013 of $1.8 million, or 6 cents per share, and expectations of Wall Street analysts.

Stock analysts surveyed by Zacks Investment Research forecast second-quarter earnings of 17 cents per share. However, before Amedisys’ June forecast, analysts had expected earnings of 1 cent per share. Analysts surveyed by Thomson Reuters forecast earnings of 4 cents per share after that announcement. Before the announcement, analysts expected Amedisys would break even for the quarter.

The price for Amedisys shares jumped 25 percent, or $4.09, to close Wednesday at $20.16. Shares spiked as high as $20.93 durng the day.

Amedisys made the improvements in profitability despite a dip in revenue from $315.7 million to $305 million. However, the company chopped $19. 3 million from its operating expenses, reducing those costs from $311.7 million to $292.4 million.

Amedisys reported a first-quarter loss of $12.4 million. But those results included $16.1 million in costs, much of that related to the expense of closing centers and restructuring. Without those expenses, Amedisys would have had a first-quarter loss of $2.2 million, or 7 cents per share.

Interim Chief Executive Officer Ronald A. LaBorde said Wednesday that much work remains, but Amedisys has re-established “a solid foundation” that will allow the company to focus on improving its core business.

Amedisys provides home health and hospice care to more than 360,000 patients annually.

More Stories